Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation.

Autor: Di Bernardo, M C¹, Broderick, P¹, Harris, S¹, Dyer, M J S², Matutes, E³, Dearden, C³, Catovsky, D³, Houlston, R S¹

Publikováno v: Leukemia (08876924). Jan2013, Vol. 27 Issue 1, p255-258. 4p. 1 Chart, 1 Graph.

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.

Autor: Sava GP; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Speedy HE; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Di Bernardo MC; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Dyer MJ; The Ernest and Helen Scott Haematological Research Institute, Department of Biochemistry and Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK., Holroyd A; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Sunter NJ; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Marr H; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Mansouri L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Deaglio S; Department of Medical Sciences and Human Genetics Foundation, University of Turin, Turin, Italy., Karabon L; 1] Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland [2] Department and Clinic of Urology, Wroclaw Medical University, Wroclaw, Poland., Frydecka I; Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland., Jamroziak K; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Woszczyk D; Department of Haematology, State Hospital, Opole, Poland., Juliusson G; Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Hematology and Transplantation, Lund University, Lund, Sweden., Smedby KE; Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden., Jayne S; The Ernest and Helen Scott Haematological Research Institute, Department of Biochemistry and Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK., Majid A; Medical Research Council Toxicology Unit, Leicester University, Leicester, UK., Wang Y; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Dearden C; Haemato-Oncology, Division of Pathology, The Institute of Cancer Research, Sutton, UK., Hall AG; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Mainou-Fowler T; Haematological Sciences, Medical School, Newcastle University, Newcastle upon Tyne, UK., Jackson GH; Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Summerfield G; Department of Haematology, Queen Elizabeth Hospital, Gateshead, Newcastle upon Tyne, UK., Harris RJ; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Pettitt AR; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Allsup DJ; Department of Haematology, Hull Royal Infirmary, Hull, UK., Bailey JR; Hull York Medical School and University of Hull, Hull, UK., Pratt G; Department of Haematology, Birmingham Heartlands Hospital, Birmingham, UK., Pepper C; Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK., Fegan C; Cardiff and Vale National Health Service Trust, Heath Park, Cardiff, UK., Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Catovsky D; Haemato-Oncology, Division of Pathology, The Institute of Cancer Research, Sutton, UK., Allan JM; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK.

Publikováno v: Leukemia [Leukemia] 2015 Mar; Vol. 29 (3), pp. 748-51. Date of Electronic Publication: 2014 Nov 03.